You are viewing an incomplete version of our website. Please click to reload the website as full version.

ORAI Calcium Release-Activated Calcium Modulator 1 (ORAI1) (N-Term) Peptide

Details for Product No. ABIN1382442, Supplier: Log in to see
Protein Name
  • im:7146264
  • orai1
  • tmem142a
  • zgc:109721
  • orai2
  • ORAI1
  • LOC100218031
  • CRACM1
  • ORAT1
  • TMEM142A
  • D730049H07Rik
  • Tmem142a
  • orai-1
  • RGD1311873
  • tmem142b
  • ORAI calcium release-activated calcium modulator 1b
  • ORAI calcium release-activated calcium modulator 1
  • ORAI calcium release-activated calcium modulator 2
  • orai1b
  • orai1
  • ORAI1
  • Orai1
  • LOC100218031
  • orai2
Protein Region
N-Term
Origin
Human
4
2
1
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-ORAI1 antibody (ORAI Calcium Release-Activated Calcium Modulator 1) (N-Term) (ABIN1031496)
Characteristics 18 amino acids near the amino terminus of human ORAI1
Human
Application Notes ORAI1 peptide is used for blocking the activity of ORAI1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Feske, Gwack, Prakriya, Srikanth, Puppel, Tanasa, Hogan, Lewis, Daly, Rao: "A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function." in: Nature, Vol. 441, Issue 7090, pp. 179-85, 2006 (PubMed).